Month: December 2020

Aspo Oyj: Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus Aspoa koskevan omistusosuuden muutoksesta

Written by Customer Service on December 2, 2020. Posted in Public Companies.

Aspo OyjPörssitiedote2.12.2020 klo 14:52 Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus Aspoa koskevan omistusosuuden muutoksestaAEV Capital Holding Oy on ilmoittanut, että yhtiön osuus Aspo Oyj:n osakepääomasta on ylittänyt kymmenen prosenttia (10 %). Ilmoitus sisältää seuraavat tiedot:Aspo Oyj:n osakkeiden kokonaismäärä on 31 419 779 osaketta, joilla on ääniä yhteensä 31 419 779 kappaletta.Aspo on monialayhtiö, joka omistaa ja kehittää liiketoimintoja Pohjois-Euroopan lisäksi kasvumarkkinoilla keskittyen vaativiin B-to-B -asiakkaisiin. Vahvojen yritysbrändien, ESL Shipping, Leipurin, Telko ja Kauko, tavoitteena on olla toimialojensa markkinajohtajia. Ne vastaavat omasta toiminnastaan, asiakassuhteistaan ja niiden kehittämisestä. Kokonaisuutena ne tuottavat Aspon liikearvon. Aspon konsernirakennetta ja liiketoimintoja kehitetään...

Aspo Plc: Notice of change in Aspo holdings pursuant to Chapter 9 Section 10 of the Securities Markets Act

Written by Customer Service on December 2, 2020. Posted in Public Companies.

Aspo Plc Stock Exchange ReleaseDecember 2, 2020 at 14:50 p.m.Aspo is a conglomerate that owns and develops business operations in Northern Europe and growth markets focusing on demanding B-to-B customers. Our strong company brands – ESL Shipping, Leipurin, Telko and Kauko – aim to be the market leaders in their sectors. They are responsible for their own operations, customer relationships and the development of these. Together they generate Aspo’s goodwill. Aspo’s Group structure and business operations are continually developed without any predefined schedules.

Daktronics, Inc. Announces Second Quarter Fiscal 2021 Results

Written by Customer Service on December 2, 2020. Posted in Earnings Releases And Operating Results.

BROOKINGS, S.D., Dec. 02, 2020 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ – DAKT) today reported fiscal 2021 second quarter results. Daktronics reported fiscal 2021 second quarter net sales of $127.4 million, operating income of $6.7 million, net income of $3.4 million, and earnings per diluted share of $0.08. This compares to net sales of $174.9 million, operating income of $4.8 million, net income of $7.3 million, and $0.16 per diluted share, for the second quarter of fiscal 2020. Fiscal 2021 second quarter orders were $135.7 million, compared to $151.1 million for the second quarter of fiscal 2020. Product order backlog at the end of the fiscal 2021 second quarter was $201 million, compared to $182 million a year earlier and $192 million at the end of the first quarter of fiscal 2021.(1)For the six months ended October 31,...

Orphazyme establishes U.S. headquarters in Chicago as the company prepares for commercialization

Written by Customer Service on December 2, 2020. Posted in Public Companies.

Orphazyme A/SInvestor news No. 07/2020 Company Registration No. 32266355·Global executive team expanding to support growth plans with three U.S.-based leadersCopenhagen, Denmark, Chicago, Illinois, USA, December 2, 2020 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announced it has established its U.S. headquarters in Chicago.Orphazyme already has recruited more than 30 U.S. employees and recently named three U.S.-based leaders to its global executive team. Molly Painter, U.S. President, is heading the...

Skeljungur hf.: Major shareholder announcement – 365 hf.

Written by Customer Service on December 2, 2020. Posted in Public Companies.

See notice in the attachment. Attachment20201202_-_Skeljungur_-_365_hf._-_Flöggun

Skeljungur hf.: Flöggun – 365 hf.

Written by Customer Service on December 2, 2020. Posted in Public Companies.

Sjá flöggunartilkynningu í viðhengi.Viðhengi20201202_-_Skeljungur_-_365_hf._-_Flöggun

Eldorado Gold Releases Updated Reserve and Resource Statement

Written by Customer Service on December 2, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 02, 2020 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or “the Company”) today releases its updated Reserve and Resource estimates as of September 30, 2020.Reserves UpdateThe Company’s Proven and Probable gold Reserves totalled 17.7 million ounces as of September 30, 20201, compared to 17.5 million ounces as of December 31, 2019, an increase of 1.3%. The complete Mineral Reserve and Resource listing can be found at the end of this release and includes the data for tonnes, grades and contained metal.The slight increase in overall Proven and Probable Reserves was attributable to increases at Kisladag, Lamaque and Perama Hill, offset by decreases at Olympias and Efemcukuru. At Kisladag, Mineral Reserves increased due to a combination of a higher long-term gold price assumption ($1,300/oz...

Immatics Announces Third Quarter 2020 Financial Results and Business Update

Written by Customer Service on December 2, 2020. Posted in Earnings Releases And Operating Results.

ACTengine® IMA200 clinical trial series continues scaling globally; initial analysis for patients in ACTengine® dose escalation is on track for Q1 2021Expansion of UTHealth partnership secures cell therapy manufacturing capacities until end of 2024Positive pre-clinical data updates on ACTengine® IMA204 and first TCR Bispecifics (TCER™) program IMA401Strengthened leadership team with appointment of Arnd Christ as Chief Financial Officer and addition of Eliot Forster to Immatics’ Board of DirectorsCash and cash equivalents as well as other financial assets of €259.3 million ($303.6 million1) as of September 30, 2020 provide cash reach into 2023 Tuebingen, Germany and Houston, TX, December 2, 2020 – Immatics N.V. (NASDAQ: IMTX; “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting...

Immatics veröffentlicht Ergebnisse des dritten Quartals 2020 sowie ein Update zur Geschäftsentwicklung

Written by Customer Service on December 2, 2020. Posted in Earnings Releases And Operating Results.

Die ACTengine® IMA200-Serie mit mehreren klinischen Programmen wird weiter global ausgebaut; erste Analyse zur Dosiseskalation weiterhin für das erste Quartal 2021 geplant.Verlängerung der Kollaboration mit dem University of Texas Health Science Center Houston (UTHealth) sichert Zelltherapie-Herstellungsstätte bis Ende 2024.Positive präklinische Daten zum ACTengine® Programm IMA204 und zu erstem bispezifischem TCR-Programm IMA401 (TCER™) veröffentlicht.Geschäftsführung mit Arnd Christ als Finanzvorstand verstärkt sowie Eliot Forster in den Aufsichtsrat berufen.Am 30. September 2020 verfügte Immatics über liquide Mittel in Höhe von 259,3 Millionen Euro (303,6 Millionen US-Dollar1), damit sind die Betriebskosten voraussichtlich bis in 2023 hinein gedeckt. Tübingen, Deutschland und Houston, Texas, 2. Dezember 2020 – Immatics N.V. (NASDAQ:...

Adamas Announces Agreement to Amend Royalty-Backed Loan Agreement with HealthCare Royalty Partners

Written by Customer Service on December 2, 2020. Posted in Public Companies.

EMERYVILLE, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has entered into an agreement to amend certain key terms of its Royalty-Backed Loan agreement (“Royalty-Backed Loan”) with HealthCare Royalty Partners (“HCR”). The key terms amended are summarized as follows:   Revised to provide for repayment from a royalty on OSMOLEX ER® on the same terms as, and in addition to, the royalty for GOCOVRI®. Eliminated the potential royalty rate step-up to 17.5%, which would have occurred in 2022 if cumulative payments did not reach minimum specified levels by December 31, 2021. The 22.5% royalty rate step-up if total cumulative payments have not...

Month: December 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals